V.F.Snegirev Archives of Obstetrics and GynecologyV.F.Snegirev Archives of Obstetrics and Gynecology2313-87262687-1386Eco-Vector5692710.17816/2313-8726-2020-7-4-176-190Research ArticleModern ideas about toxoplasmosisKaptilnyyV. A.1mgmu@mail.ruReyshtatD. Yu.Diana.reyshtat@mail.ruFirst Moscow State Medical University271220207417619025122020Copyright © 2020, Eco-Vector2020<p><em>Toxoplasmosis is an infectious disease caused by Toxoplasma gondii, a protozoan, intracellular parasite that infects up to a third of the Worlds population. Infection occurs when food or water is consumed with oocysts secreted from cat feces, or by eating undercooked or raw meat containing cysts.</em></p>
<p><em>Primary infection is usually subclinical, but some patients may have lymphadenopathy or eye disease such as chorioretinitis. An infection acquired during pregnancy can cause serious damage to the fetus. In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.</em></p>
<p><em>The diagnosis of toxoplasmosis can be established by direct detection of the parasite or using serological methods.</em></p>
<p><em>The most commonly used and probably most effective therapeutic treatment is a combination of pyrimethamine with sulfadiazine and folic acid.</em></p>
<p><em>The review contains information on the management of patients with acute Toxoplasma infection, as well as pregnant women infected during pregnancy. The issues of fetal toxoplasmosis and neonatal toxoplasmosis, eye diseases associated with toxoplasmosis, and the course of toxoplasmosis in immunocompromised individuals are discussed. Contradictions concerning the effectiveness of primary and secondary prevention in pregnant women are considered.</em></p>toxoplasmosisToxoplasma gondii life cycleT. gondii diagnosistoxoplasmosis treatmentтоксоплазмозжизненный цикл Toxoplasma gondiiдиагностика T. gondiiлечение токсоплазмоза[Cornelissen AW, Overdulve JP, van der Ploeg M. Determination of nuclear DNA of five eucoccidian parasites, Isospora (Toxoplasma) gondii, Sarcocystis cruzi, Eimeria tenella, E acervulina and Plasmodium berghei, with special reference to gamontogenesis and meiosis in I (T.) gondii. Parasitology. 1984;88:531–553.][Frenkel JK. Toxoplasmosis: parasite life cycle pathology and immunology. In: Hammond DM, Long PL, eds. The Coccidia. Baltimore: University Park Press; 1973. p. 343–410.][Sibley LD, Boothroyd JC. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 1992;359:82–85.][Ajzenberg D, Cogne N, Paris L, et al. Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings. J Infect Dis. 2002;186:684–689. doi: 10.1086/342663. Epub 2002 Aug 5][Desmonts G, Couvreur J, Alison F, Baudelot J, Gerbeaux J, Lelong M. Etude epidemiologique sur la toxoplasmose: ľinfluence de la cuisson des viandes de boucherie sur la frequence de ľinfectin humaine. Rev Fr Etud Clin Biol. 1965;10:952–958.][Dubey JP, Gamble HR, Hill D, Sreekumar C, Romand S, Thuilliez P. High prevalence of viable Toxoplasma gondii infection in market weight pigs from a farm in Massachusetts. J Parasitol. 2002;88:1234–1238. doi: 10.1645/0022-3395(2002)088[1234:HPOVTG]2.0.CO;2][Brooks RG, Remington JS. Transplant-related infections. In: Bennett JV, Brachman PS, eds. Hospital infections. 2nd ed. Boston: Little, Brown and Co; 1986. p. 581–618.][Kayhoe DE, Jacobs L, Beye HK, McCullough NB. Acquired toxoplasmosis: observations on two parasitologically proved cases treated with pyrimethamine and triple sulfonamides. N Engl J Med. 1957;257:1247–1254.][Gavinet MF, Robert F, Firtion G, et al. Congenital toxoplasmosis due to maternal reinfection during pregnancy. J Clin Microbiol. 1997;35:1276–1277.][Hohlfeld P, Daffos F, Costa J-M, Thuylliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with polymerase-chainreaction test on amniotic fluid. N Engl J Med. 1994;331:695–699.][European Collaborative Study and Research Network on Congenital Toxoplasmosis. Low incidence of congenital toxoplasmosis in children born to women infected with human immunodeficiency virus. Eur J Obstet Gynecol Reprod Biol. 1996;68(1-2):93–96. doi: 1016/0301-2115(96)02497-9][Forsgren M, Gille E, Ljungstrom I, Nokes DJ. Toxoplasma gondii antibodies in pregnant women in Stockholm in 1969, 1979, and 1987. Lancet. 1991;337:1413–1414.][Morrissette NS, Sibley LD. Cytoskeleton of apicomplexan parasites. Microbiol Mol Biol Rev. 2002;66:21–38. doi: 10.1128/mmbr.66.1.21-38.2002][Chardes T, Buzoni-Gatel D, Lepage A, Bernard F, Bout D. Toxoplasma gondii oral infection induces specific cytotoxic CD8α/β+Thy-1+gut intraepithelial lymphocytes, lytic for parasite-infected enterocytes. J Immunol. 1994;153:4596–4603.][Sousa C Reis e, Hieny S, Scharton-Kersten T, et al. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas. J Exp Med. 1997;198:1819–1829. doi: 10.1084/jem.186.11.1819][Montoya JG, Lowe KE, Clayberger C, et al. Human CD4+ and CD8+ T lymphocytes are both cytotoxic to Toxoplasma gondii-infected cells. Infect Immun. 1996;64:176–181. doi: 10.1128/IAI.64.1.176-181.1996][Chardes T, Bourguin I, Mevelec M-N, Dubremetz J-F, Bout D. Antibody responses to Toxoplasma gondii in sera, intestinal secretions, and milk from orally infected mice and characterization of target antigens. Infect Immun. 1990;58:1240–1246. doi: 10.1128/IAI.58.5.1240-1246.1990][Dorfman RF, Remington JS. Value of lymph-node biopsy in the diagnosis of acute acquired toxoplasmosis. N Engl J Med. 1973;289:878–881.][Holland GN, O’Connor GR, Belfort R Jr, Remington JS. Toxoplasmosis. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St. Louis: Mosby Yearbook; 1996. p. 1183–1223.][Luft BJ, Conley F, Remington JS, et al. Outbreak of central-nervoussystem toxoplasmosis in western Europe and North America. Lancet. 1983;1:781–784.][Luft BJ, Remington JS. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992;15:211–222. doi: 10.1093/clinids/15.2.211][Mariuz P, Bosler EM, Luft BJ. Toxoplasma pneumonia. Semin Respir Infect. 1997;12:40–43.][Montoya JG. Laboratory diagnosis of Toxoplasma gondii infection and toxoplasmosis. J Infect Dis. 2002;185(Suppl 1):S73–S82.][Liesenfeld O, Wong SY, Remington JS. Toxoplasmosis in the setting of AIDS. In: Bartlett JG, Merigan TC, Bolognesi D, eds. Textbook of AIDS medicine. 2nd ed. Baltimore: Williams & Wilkins; 1999. p. 225–259.][Luft BJ, Hafner R, Korzun AH, et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engl J Med. 1993;329:995–1000. doi: 10.1056/NEJM199309303291403][Gay-Andrieu F, Marty P, Pialat J, Sournies G, Drier de Laforte T, Peyron F. Fetal toxoplasmosis and negative amniocentesis: necessity of an ultrasound follow-up. Prenat Diagn. 2003;23:558–560. doi: 10.1002/pd.632][McAuley J, Boyer KM, Patel D, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis. 1994;18:38–72. doi: 10.1093/clinids/18.1.38][28. Cazenave J, Cheyrou A, Blouin P. Use of polymerase chain reaction to detect Toxoplasma. J Clin Pathol. 1991;44:1037–1039. doi: 10.1136/jcp.44.12.1037-a][Hedman K, Lappalainen M, Seppala I, Makela O. Recent primary Toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis. 1989;159:736–739. doi: 10.1093/infdis/159.4.736][Jenum PA, Stray-Pedersen B, Gundersen A-G. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G activity. J Clin Microbiol. 1997;35:1972–1977. doi: 10.1128/JCM.35.8.1972-1977.1997][Naot Y, Desmonts G, Remington JS. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr. 1981;98:32–36.][Decoster A, Slizewicz B, Simon J, et al. Platelia-toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol. 1991;29:2291–2295. doi: 10.1128/JCM.29.10.2291-2295.1991][Wong SY, Hadju M-P, Ramirez R, Thulliez P, McLeod R, Remington JS. The role of specific immunoglobulin E in diagnosis of acute toxoplasma infection and toxoplasmosis. J Clin Microbiol. 1993;31:2952–2959. PMCID: PMC266169][Fardeau C, Romand S, Rao NA, et al. Diagnosis of toxoplasmic retinochoroiditis with atypical clinical features. Am J Ophthalmol. 2002;134:196–203. doi: 10.1016/s0002-9394(02)01500-3][Liesenfeld O, Montoya JG, Tathineni NJ, et al. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. Am J Obstet Gynecol. 2001;184:140–145. doi: 10.1067/mob.2001.108341][Wong S, Remington JS. Toxoplasmosis in pregnancy. Clin Infect Dis. 1994;18:853–862. doi: 10.1093/clinids/18.6.853][Gras L, Gilbert RE, Ades AE, Dunn DT. Effect of prenatal treatment on the risk of intracranial and ocular lesions in children with congenital toxoplasmosis. Int J Epidemiol. 2001;30:1309–1313. doi: 10.1093/ije/30.6.1309][Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002;134:102–114. doi: 10.1016/s0002-9394(02)01526-x][Luft BJ, Billingham M, Remington JS. Endomyocardial biopsy in the diagnosis of toxoplasmic myocarditis. Transplant Proc. 1986;18:1871–1873.][Montoya JG, Remington JS. Toxoplasma gondii. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and practice of infectious diseases. Philadelphia: Churchill Livingstone; 2000. p. 2858–2888.][Torre D, Casari S, Speranza F, et al. Randomized trial of trimethoprim-sulfamethoxazole versus pyrimethamine-sulfadiazine for therapy of toxoplasmic encephalitis in patients with AIDS. Antimicrob Agents Chemother. 1998;42:1346–1349. doi: 10.1128/AAC.42.6.1346][Eskild A, Oxman A, Magnus P, Bjorndal A, Bakketeig LS. Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen. 1996;3:188–194. doi: 10.1177/096914139600300406][Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology. 1995;110:11–16. doi: 10.1017/s003118200000144x][Petersen E, Nielsen HV, Christiansen L, Spenter J. Immunization with E coli produced recombinant T gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine. 1998;16:1283–1289. doi: 10.1016/s0264-410x(98)00039-5]